tiprankstipranks
Trending News
More News >
Nova Eye Medical (ELXMF)
OTHER OTC:ELXMF

Nova Eye Medical (ELXMF) Price & Analysis

Compare
9 Followers

ELXMF Stock Chart & Stats

$0.25
$0.00(0.00%)
At close: 4:00 PM EDT
$0.25
$0.00(0.00%)

Bulls Say, Bears Say

Bulls Say
Revenue GrowthConsistent revenue growth (12.09% last year) indicates expanding product adoption in ophthalmic surgery. Sustained top-line growth supports scale across manufacturing and distribution, improving the odds of long-term margin recovery and investment return over months.
Low Financial LeverageA low debt-to-equity ratio (0.16) limits solvency risk and preserves financial flexibility. This capital structure gives management room to fund product development or commercial expansion without heavy interest burdens, supporting durable operational resilience.
Specialized Ophthalmic ConsumablesFocus on surgical devices and consumables creates recurring consumable demand and specialized clinical relationships. Consumables drive repeat revenue and stickiness with clinics and surgeons, underpinning a durable revenue base and competitive positioning over months.
Bears Say
Negative Cash GenerationOngoing negative operating and free cash flows mean the business burns cash to run operations and invest. Persisting cash deficits constrain organic R&D, marketing and manufacturing scale, increasing dependence on external funding and raising dilution or liquidity risk.
Declining Gross MarginA material drop in gross margin suggests rising product costs or pricing pressure in core markets. Margin erosion undermines sustainable profitability, reduces cash conversion on incremental sales, and makes it harder to fund fixed costs while scaling the business.
Negative Profitability / ROESustained negative net profit and EBIT margins, along with negative ROE, show the company is not generating returns on shareholder capital. This persistent lack of profitability pressures capital providers and can force strategic trade-offs or additional financing.

Nova Eye Medical News

ELXMF FAQ

What was Nova Eye Medical’s price range in the past 12 months?
Nova Eye Medical lowest stock price was $0.10 and its highest was $0.25 in the past 12 months.
    What is Nova Eye Medical’s market cap?
    Nova Eye Medical’s market cap is $29.85M.
      When is Nova Eye Medical’s upcoming earnings report date?
      Nova Eye Medical’s upcoming earnings report date is Aug 27, 2026 which is in 165 days.
        How were Nova Eye Medical’s earnings last quarter?
        Nova Eye Medical released its earnings results on Feb 25, 2026. The company reported -$0.008 earnings per share for the quarter, missing the consensus estimate of -$0.003 by -$0.005.
          Is Nova Eye Medical overvalued?
          According to Wall Street analysts Nova Eye Medical’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Nova Eye Medical pay dividends?
            Nova Eye Medical pays a Notavailable dividend of $0.294 which represents an annual dividend yield of N/A. See more information on Nova Eye Medical dividends here
              What is Nova Eye Medical’s EPS estimate?
              Nova Eye Medical’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Nova Eye Medical have?
              Nova Eye Medical has 284,840,270 shares outstanding.
                What happened to Nova Eye Medical’s price movement after its last earnings report?
                Nova Eye Medical reported an EPS of -$0.008 in its last earnings report, missing expectations of -$0.003. Following the earnings report the stock price went same 0%.
                  Which hedge fund is a major shareholder of Nova Eye Medical?
                  Currently, no hedge funds are holding shares in ELXMF
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Nova Eye Medical Stock Smart Score

                    Company Description

                    Nova Eye Medical

                    Nova Eye Medical Limited designs, develops, distributes, markets, sells, and services surgical devices for the treatment of glaucoma. The company offers iTrack, a surgical system for the reduction in intraocular pressure (IOP) in adult patients with open-angle glaucoma; iTrack Advance, a natural ocular drainage system; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Asia Pacific, and internationally. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was founded in 1985 and is headquartered in Kent Town, Australia.

                    Nova Eye Medical (ELXMF) Earnings & Revenues

                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Compumedics Limited
                    Cyclopharm Limited
                    Micro-X Ltd.
                    EMvision Medical Devices Ltd.
                    Control Bionics Ltd.

                    Ownership Overview

                    4.89%95.11%
                    ― Other Institutional Investors
                    95.11% Public Companies and
                    Individual Investors

                    Options Prices

                    Currently, No data available
                    ---
                    Popular Stocks